The construction and application of adenovirus vector coexpressing the heterodimer of human IL-12

W. Zhang;雪涛 曹

Second Military Medical University

发表时间:1998-1

期 刊:Zhonghua yi xue za zhi

语 言:English

U R L: http://www.scopus.com/inward/record.url?scp=0031597881&partnerID=8YFLogxK

摘要

OBJECTIVE: To construct the recombinant adenovirus vector co-expressing the heterodimer of human interkeukin-12. METHODS: The full-length cDNA encoding human IL-12 subunits p40 or p35 was cloned by RT-PCR separately. The cDNA was ligated with encephalomyocarditis internal ribosome entry site (IRES), placed under the control of CMV promoter, and inserted into E1-substituted adenovirus vector pAx1cw to produce the bicistronic coexpression vector. Subsequently, the hIL-12 recombinant adenovirus vector was cotransfected into 293 cells together with EcoT22I-digested Ad5 DNA-TPC, and the replication-deficient hIL-12 recombinant adenoviruses was generated efficiently by homologous recombination. RESULTS: The human IL-12 recombinant adenoviruses were obtained with the titers of 2.1 x 10(9) pfu/ml. 48 hours after the infection of the 293 cells, HepG2 cells and human primary skin fibroblasts with hIL-12 recombinant adenoviruses, the hIL-12 expressions were detected by ELISA (30-50 ng/10(6) cells/24 h). The expressed hIL-12 could stimulate the in vitro proliferation and IFN-gamma production of human PMNC. CONCLUSION: Prepared hIL-12 recombinant adenovirus vector can express biologically active hIL-12 and can be potentially used in cancer gene therapy.

相关科学

医学

文献指纹

医学与生命科学

Interleukin-12

Adenoviridae

Complementary DNA

Internal Ribosome Entry Sites

Homologous Recombination

Neoplasm Genes

Hep G2 Cells

DNA Replication

Genetic Therapy

Fibroblasts

Enzyme-Linked Immunosorbent Assay

Polymerase Chain Reaction

Skin

Infection

In Vitro Techniques

期刊度量

Scopus度量

年份 CiteScore SJR SNIP
1996
1997
1998
1999 0.106
2000 0.11
2001 0.106
2002 0.111 0
2003 0.122 0
2004 0.138 0
2005 0.173
2006 0.15 0.078
2007 0.137 0.106
2008 0.132 0.078
2009 0.144 0.108
2010 0.122 0.088
2011 0.5 0.118 0.082
2012 0.2 0.109 0.087
2013 0.2 0.127 0.101
2014 0.2 0.138 0.104
2015 0.3 0.15 0.091
2016 0.3 0.151 0.098
2017 0.3 0.143 0.093
2018 0.3 0.153 0.082
2019 0.3 0.155 0.106
2020 0.4

相似文献推荐